Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.5.1.52 (
PNGase F
)
1,527
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Human
vascular adhesion protein-1
(
VAP-1
) is a dual-function molecule with adhesive and enzymatic properties. In addition to synthesis in endothelial cells, where it mediates lymphocyte binding,
VAP-1
is expressed in smooth muscle cells. Here we studied the expression, biochemical structure, and function of
VAP-1
in muscle cells and compared it to those in endothelial cells.
VAP-1
is expressed on the plasma membrane of all types of smooth muscle cells, but it is completely absent from cardiac and skeletal muscle cells. In tumors,
VAP-1
is retained on all leiomyoma cells, whereas it is lost in half of leiomyosarcoma samples. In smooth muscle
VAP-1
predominantly exists as a approximately 165-kd homodimeric glycoprotein, but a trimeric (approximately 250 kd) form of
VAP-1
is also found. It contains N-linked oligosaccharide side chains and abundant sialic acid decorations. In comparison, in endothelial cells dimeric
VAP-1
is larger, no trimeric forms are found, and
VAP-1
does not have
N-glycanase
-sensitive oligosaccharides. Unlike endothelial
VAP-1
,
VAP-1
localized on smooth muscle cells does not support binding of lymphocytes. Instead, it deaminates exogenous and endogenous primary amines. In conclusion,
VAP-1
in smooth muscle cells is structurally and functionally distinct from
VAP-1
present on endothelial cells.
...
PMID:Human vascular adhesion protein-1 in smooth muscle cells. 1059 25